Centric Health Corp. (TSE:CRX – Free Report) – Ventum Cap Mkts decreased their Q4 2024 earnings estimates for shares of Centric Health in a report issued on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now forecasts that the company will earn ($0.01) per share for the quarter, down from their prior estimate of $0.01. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. Ventum Cap Mkts also issued estimates for Centric Health’s FY2025 earnings at $0.15 EPS.
Separately, Stifel Canada cut shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th.
Centric Health Stock Performance
Featured Stories
- Five stocks we like better than Centric Health
- Which Wall Street Analysts are the Most Accurate?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is the Dogs of the Dow Strategy? Overview and Examples
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
